Itopride is a prokinetic benzamide derivative acting as both a dopamine D2 receptor antagonist and an acetylcholinesterase inhibitor, widely prescribed for treating functional dyspepsia, gastroesophageal… Read more


![Chemical structure of 3,4-Dimethoxy-N-[(4-methoxyphenyl)methyl]benzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F331239-23-7-34-Dimethoxy-N-4-methoxyphenylmethylbenzamide.png&w=3840&q=75)





![Chemical structure of 4-[2-(Dimethylamino)ethoxy]benzonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F24197-95-3-4-2-Dimethylaminoethoxybenzonitrile.png&w=3840&q=75)
![Chemical structure of 4-[2-(Dimethylamino)ethoxy]benzylamine Dihydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F886448-11-9-4-2-Dimethylaminoethoxybenzylamine-Dihydrochloride.png&w=3840&q=75)












Itopride is a prokinetic benzamide derivative acting as both a dopamine D2 receptor antagonist and an acetylcholinesterase inhibitor, widely prescribed for treating functional dyspepsia, gastroesophageal reflux disease, and various gastrointestinal motility disorders. Pharmaceutical laboratories utilize reference standards of Itopride and its related compounds to ensure the precision and reliability of analytical procedures. This collection includes critical degradation products, metabolites, and N-nitroso or N-desmethyl impurities necessary for comprehensive impurity profiling. Additionally, stable isotope labelled compounds are available to serve as internal standards during mass spectrometry-based assays. These materials are essential for rigorous quality control, method validation, and stability testing, allowing researchers to accurately monitor the drug product's safety and potency throughout its development and manufacturing lifecycle.